INTRODUCTION: Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) often requiring immunomodulatory therapy. This report presents a case of severe pneumonia in a UC patient treated with infliximab, an anti-tumor necrosis factoralpha agent. It highlights the diagnostic challenges in distinguishing between pulmonary extra-intestinal manifestations (EIM) of UC, infectious or autoimmune-related pneumonia, and drug-induced organizing pneumonia (OP).
Burden Beyond the Bowel: An Insightful Case of Severe Pneumonia in a Patient with Ulcerative Colitis on Infliximab Therapy
Marchi, G.;Guglielmi, G.;Pistelli, F.;Carrozzi, L.
2025-01-01
Abstract
INTRODUCTION: Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) often requiring immunomodulatory therapy. This report presents a case of severe pneumonia in a UC patient treated with infliximab, an anti-tumor necrosis factoralpha agent. It highlights the diagnostic challenges in distinguishing between pulmonary extra-intestinal manifestations (EIM) of UC, infectious or autoimmune-related pneumonia, and drug-induced organizing pneumonia (OP).File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
